rs190548814
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_017780.4(CHD7):c.3697G>A(p.Gly1233Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000423 in 1,613,946 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_017780.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHD7 | ENST00000423902.7 | c.3697G>A | p.Gly1233Ser | missense_variant | Exon 15 of 38 | 5 | NM_017780.4 | ENSP00000392028.1 | ||
CHD7 | ENST00000524602.5 | c.1717-31733G>A | intron_variant | Intron 2 of 4 | 1 | ENSP00000437061.1 | ||||
CHD7 | ENST00000695853.1 | n.3697G>A | non_coding_transcript_exon_variant | Exon 15 of 37 | ENSP00000512218.1 |
Frequencies
GnomAD3 genomes AF: 0.00218 AC: 332AN: 152164Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000626 AC: 156AN: 249276Hom.: 1 AF XY: 0.000555 AC XY: 75AN XY: 135238
GnomAD4 exome AF: 0.000239 AC: 350AN: 1461664Hom.: 2 Cov.: 32 AF XY: 0.000231 AC XY: 168AN XY: 727118
GnomAD4 genome AF: 0.00219 AC: 333AN: 152282Hom.: 2 Cov.: 32 AF XY: 0.00218 AC XY: 162AN XY: 74458
ClinVar
Submissions by phenotype
not specified Benign:4
- -
p.Gly1233Ser in exon 15 of CHD7: This variant is not expected to have clinical s ignificance because it has been identified in 0.87% (85/9800) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs190548814). -
- -
- -
not provided Benign:4
This variant is associated with the following publications: (PMID: 30653986) -
CHD7: BS1, BS2 -
- -
- -
CHARGE syndrome Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at